-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Jasper Therapeutics, Inc. annual/quarterly Depreciation, Depletion and Amortization history and growth rate from Q3 2022 to Q3 2023.
- Jasper Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2023 was $300K, unchanged year-over-year.
- Jasper Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $1.11M, a 13.6% increase from 2022.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)